Navigation Links
Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17, 2009 at 4:15 p.m. ET
Date:6/15/2009

IRVINE, Calif., June 15 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced that John McDermott, President and CEO, is scheduled to deliver a presentation to the investment community on Wednesday, June 17, 2009 at 4:15 pm ET as part of the SMH Capital Small Cap Spotlight Series. Mr. McDermott will provide a general corporate overview and an update on the Company's recently launched products. He will also participate in a live question and answer session.

Participants can pre-register for the event by visiting the following Web link: https://www2.gotomeeting.com/register/741291363. A live Web cast of the presentation will also be made available on the Investor Relations section of the Endologix Web site at investors.endologix.com.

About Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink(R) System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.

About SMH Market & Liquidity Services

SMH MLS LLC is an affiliate of SMH Capital Inc., a registered broker-dealer and a member of FINRA and SIPC, and a subsidiary of Sanders Morris Harris Group (Nasdaq: SMHG). SMH Market & Liquidity Services assists small cap companies seeking to expand their investor exposure and market depth and breadth through a broad spectrum of services that include comprehensive perspective reports, strategic shareholder communications, and trading analysis. SMH MLS may seek as a client the presenting company of any sponsored webinar. SMH Market & Liquidity Services receives compensation from its company clients for all communications and publications prepared on its behalf (http://www.smhmls.com). SMH MLS may engage SMH Capital to provide research coverage for one of its client. In addition, SMH Capital may provide, or may have provided, any of its services to the subject company, including market making, specialized and other proprietary trading, fund management, investment services and investment banking. This is not a solicitation to buy or offer to sell or the subject company's securities.

    COMPANY CONTACT:                              INVESTOR CONTACTS:
    Endologix, Inc.                               The Ruth Group
    John McDermott, CEO                           Nick Laudico (646) 536-7030
    (949) 595-7200                                Zack Kubow (646) 536-7020
    www.endologix.com


'/>"/>
SOURCE Endologix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Endologix Receives Nasdaq Letter on Director Independence
2. Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System
3. American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO-HOSPIRIO in Cuenca, Ecuador
4. Providence Service Corporation Announces Preliminary Results of Annual Meeting of Stockholders
5. New Online Community Answers Hospital Questions about ARRA QHR Announces Launch of theQsphere.com
6. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
7. PDI, Inc. Announces New Business Wins Exceeding $18 Million
8. Pulmo BioTech Inc. Announces Fund Raising Agreement with Moody Capital Solutions, Inc.
9. Eli Lilly and Company Announces New Drug Discovery Initiative
10. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
11. NBTY Announces Preliminary Unaudited Net Sales Results for May 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Basketball is a game for everyone, not ... Peety PoppersTM series, sign language translation is featured in the top right of the ... Peety PoppersTM lessons has a sign language translator to teach kids the game and ...
(Date:2/11/2016)... ... February 12, 2016 , ... Fitbody Personal Training offers outdoor training ... exciting way to get fit and healthy. Located in Phoenixville, PA, the classes are ... class designed for horseback riders who want to lose weight and tone up. This ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... participated in the American Osteopathic Association’s (AOA) Match Program Tuesday, February 9, taking ... Program places students into osteopathic graduate medical education positions across the country. Of ...
(Date:2/11/2016)... ... February 12, 2016 , ... The Journal of ... from 0.416 in 2013. The SJR uses data taken from the Scopus database (Elsevier ... the number of citations received by the journal over a three year period and ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... diabetes has been gearing up for their simultaneous grand openings in March. All ... right now that you’re probably wondering, is reversing diabetes possible? According to this ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... 11, 2016 The primary goal of this ... patterns on the usage of liquid biopsy. Key information ... - Timeframe of liquid biopsy adoption amidst future ... Evs—by organization type - Sample inflow to conduct liquid ... stool, serum, and so on. - Correlation analysis of ...
Breaking Medicine Technology: